Fernando Palacios Salas

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Miguel Martín, Monserrat Muñoz, A. Balil et al. · The Lancet Oncology · 2007 · 186 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +7

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Intermittent continuous iv infusion of high-dose cyclophosphamide for remission induction in acute lymphocytic leukemia.

A Solidoro, Jorge Otero, Carlos Vallejos et al. · PubMed · 1981 · 17 citations

Immunology, Pharmacotherapy, Immunotherapy +19

A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis

K. Bouzid, J. Vinholes, Fernando Palacios Salas et al. · European Journal of Cancer · 2001 · 10 citations

Interim Analysis, Advanced Breast Cancer, Breast Oncology +8